Scientists Accuse Government of Dishonesty Over GM Babies in its Regulation of new IVF Technique
By Steve Connor,
The Independent
| 07. 28. 2014
Untitled Document
The Government has been accused of misleading the public over the introduction of a new in vitro fertilisation (IVF) technique that some experts believe will result in the birth of “genetically modified babies”.
Leading scientists, including Lord Winston, an early pioneer of fertility treatment, have criticised the Department of Health for trying to play down a process that will for the first time allow the alteration of the DNA of future generations.
They argue that the Government has redefined the term “genetic modification” (GM) to exclude specifically a controversial technique that will result in babies inheriting genetic material from three individuals.
The move, buried within a Department of Health document published last week, is designed to take the sting out of hostility towards mitochondrial donation – a process that aims to avoid the certain inherited diseases being passed on by using healthy mitochondria (microscopic structures in the cell) taken from a donor egg or embryo. Opponents believe that using the healthy donor mitochondria will result in “three-parent embryos” and could usher in an era of “designer babies”...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
